Negros Occidental Braces For Thousands At Holy Week Pilgrimage Sites

Para sa mga naghahanap ng kapayapaan at espiritwal na pagninilay, handa ang Negros Occidental ngayong Mahal na Araw.

Sipalay Accommodations 90% Booked For Holy Week Break

Ang mga turista ay masigasig na dumadagsa sa Sipalay dahil sa halos punong mga akomodasyon para sa Holy Week.

PCG Awards Purchase Deal For 40 Patrol Boats To French Firm

Inanunsyo ng PCG ang kasunduan sa OCEA para sa pagbili ng 40 patrol boats. Ito ay isang makabagong hakbang tungo sa mas mahusay na serbisyo sa bayan.

Quezon City Urges Schools To Adopt Sustainable Practices Amid Climate Crisis

Ang Quezon City ay nag-uudyok sa mga paaralan na pagtibayin ang kanilang mga pagsisikap sa kapaligiran para sa mas magandang kinabukasan.

Global Coronavirus Cases Surpass 40M

The number of the COVID-19 cases in the world has surpassed 40 million on Monday.
By The Visayas Journal

Global Coronavirus Cases Surpass 40M

0
0

How do you feel about this story?

Like
Love
Haha
Wow
Sad
Angry

The number of the coronavirus disease 2019 (Covid-19) cases in the world has surpassed 40 million early Monday, according to Johns Hopkins University data.

More than 1.11 million people have lost their lives around the world from Covid-19 so far.

The US still leads the world in the number of Covid-19 cases with over 8.15 million, while deaths are at almost 220,000.

In India, more than 7.55 million people contracted the virus with a death toll of over 114,600. Brazil has more than 5.22 million cases and a death toll exceeding 153,600.

China, the birthplace of Covid-19, has close to 91,000 cases with 4,739 deaths.

The UK’s Scientific Advisory Group for Emergencies said Sunday more than one coronavirus vaccine will be available at the beginning of 2021.

American pharmaceutical firm Pfizer said Friday it may know the effectiveness of its vaccine by the end of October, and it is planning to submit safety data on the final dose of the vaccine to the US Food and Drug Administration in the third week of November.

A vaccine candidate developed by the Beijing Institute of Biological Products, affiliated to the state-owned China National Pharmaceutical Group (Sinopharm), elicited antibody response in recipients, according to a study published Thursday in the Lancet Infectious Diseases journal.

Meanwhile, Russian President Vladimir Putin said Wednesday that a second coronavirus vaccine, EpiVakKorona, has been granted regulatory approval.

There are more than 170 vaccines around the world that are candidates for Covid-19 and tracked by the World Health Organization, but none has been approved for general use yet. (PNA)